This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CLR 1602

Cellectar Biosciences, Inc.

Drug Names(s): CLR 1602-PTX, CLR-1602-PTX, CLR-1602, CLR1602, Cellectar-1, reformulation paclitaxel

Description: CLR 1602 is a paclitaxel chemotherapeutic conjugate. Based on the company's technology platform, CLR 1602 is most likely the chemotherapy, paclitaxel, conjugated to a phospholipid ether analog (PLE) carrier designed to increase uptake in tumor cells.


CLR 1602 News

Pink Sheet Novartis Diovan HCT


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug